Lioton (Heparin Sodium)

Heparin sodium binds to antithrombin III, accelerating its inhibition of thrombin (factor IIa) and factor Xa. This blocks key steps in the coagulation cascade, reducing fibrin generation and thereby preventing the formation and extension of blood clots at the site where the product is applied.

The appropriate dose of Lioton is determined by the prescribing clinician based on the patient’s condition, the area to be treated, and the intended duration of therapy. Healthcare providers select the amount and frequency of application that best balances efficacy with safety for each individual case.

Safety of topical heparin during pregnancy or lactation has not been fully established. It should be used only if the potential benefit outweighs any possible risk, and the decision must be made by a qualified healthcare professional after evaluating the specific clinical situation.

To place an order, submit an enquiry on the Lioton product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with systemic anticoagulants such as warfarin or direct oral agents, Lioton offers localized anticoagulation with minimal systemic exposure, reducing the risk of widespread bleeding. Unlike other topical agents, heparin sodium provides a well‑characterized mechanism through antithrombin activation, making it a preferred choice for targeted clot prevention when appropriate.

Lioton should be stored below 25 °C in its original container, protected from moisture and direct light. Keep the product out of reach of children and avoid exposing it to extreme temperatures. Before use, inspect the preparation for any discoloration or contamination and discard if the integrity is compromised.

Lioton is applied directly to the skin over the affected area. The prescribed amount is spread thinly and gently massaged until absorbed, following the healthcare provider’s instructions regarding frequency and duration. Hands should be washed before and after application to maintain hygiene.

The most serious risks include severe allergic reactions such as anaphylaxis, significant bleeding beyond the application site, and the rare development of heparin‑induced thrombocytopenia (HIT). Patients should be monitored for signs of rash, swelling, unexpected bruising, or a sudden drop in platelet count and seek immediate medical attention if these occur.

Lioton should not be used by individuals with a known hypersensitivity to heparin or any of its excipients, on open wounds or areas with active bleeding, and in patients receiving other anticoagulant or antiplatelet therapies unless specifically directed by a clinician. Pregnant or nursing women should only use it after a risk‑benefit assessment by their healthcare provider.